P3 Health Partners Announces Second Quarter 2026 Results
P3 Health Partners Inc. (PIII) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 P3 Health Partners Announces Second Quarter 2026 Results Raises Full-Year 2026 Adjusted EBITDA Guidance Management to Host Conference Call and Webcast August 10, 2026 at 4:30 PM ET HENDERSON, NV—August 10, 2026—P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ:
How this was made
The 30-second read
Why it matters
Q2 showed a swing to positive net income and a large improvement in adjusted EBITDA versus the prior-year quarter, prompting management to raise full-year adjusted EBITDA guidance.
Market read
Traders can update models immediately using the revised 2026 adjusted EBITDA range and the reported Q2 profitability metrics, with the call at 4:30 PM ET as a near-term catalyst.
What to watch
At-risk membership declined 10% YoY to ~105,000, which could offset margin gains if payer rationalization continues or if rate progression slows.
Background
P3 Health Partners is a population health management company reporting quarterly results and providing revised full-year non-GAAP guidance.
Ticker impact
P3 reported Q2 2026 results and raised full-year 2026 adjusted EBITDA guidance to $80 million to $110 million.
Likely positive near-term bias as traders price the raised adjusted EBITDA range and improved medical margin/EBITDA trajectory.
The filing includes specific Q2 adjusted EBITDA of $54.4 million and a revised full-year adjusted EBITDA range ($80m to $110m), both time-sensitive and directly tied to management’s outlook.
Market effects
Reinforces investor appetite for value-based population health operators showing contract and network execution improvements.
No specific regional spillover beyond US healthcare services.
Limited, company-specific US healthcare services update.
Counterpoint
Adjusted EBITDA and medical margin include favorable payer settlements and prior-year development, so the quality and sustainability of the improvement may be questioned.
Key entities
- companyP3 Health Partners Inc.
NASDAQ-listed population health management company filing an 8-K with Q2 results and revised 2026 adjusted EBITDA guidance.
- executiveDr. Aric Coffman
CEO quoted stating Q2 execution supports raising full-year 2026 adjusted EBITDA outlook.
